HIV-RESISTANT CAR T CELLS BY CRISPR/Cas-MEDIATED CAR INTEGRATION INTO THE CCR5 LOCUS
Background: The HIV reservoir is a major barrier to a cure. To augment T cell mediated eradication of infected cells, we have engineered chimeric antigen receptor (CAR) T cells using a single-chain variable fragment (scFv) from the clinically potent broadly neutralizing antibody (bNAb) 10-1074. We used the CRISPR/Cas9 system to integrate the CAR expression cassette…